L’Oréal announced December 23 the signing of an agreement to acquire the Japanese company Takami Co., as it was informed by the Company.
Takami Co. develops and markets products licensed by the skincare brand Takami, owned by Doctor Hiroshi Takami, founder of two eponymous dermatological clinics in Tokyo. On this occasion, L’Oréal also renewed a very long term brand licensing agreement with Doctor Takami and signed a collaboration contract with the Takami clinics. This acquisition should be completed in the next few weeks.
The Takami brand, founded in 1999, is a premium skincare brand, expert in peeling, based on the know-how of the famous eponymous dermatological and aesthetic clinics. Mainly available in Japan and in some Asian countries, notably in China where it enjoys strong appeal, the brand is marketed through an omnichannel distribution. The brand achieved sales revenue of about €50M in 2019 and continues its growth this year despite difficult market conditions due to Covid-19 impacts.
L’Oréal has unique international portfolio of 36 diverse and complementary brands. The Group generated sales amounting to 29.87 billion euros in 2019. As the world’s leading beauty company, L’Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail, branded retail and e-commerce.